InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Mika Yuval. Director active across 1 company, notably Orchestra BioMed Holdings, Inc.. Aggregated, 4 disclosures have been published. Activity tracked since 20 July 2023. The latest transaction was filed on 8 May 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Mika Yuval has filed 4 reports in total. The 4 sampled filings, all related to Orchestra BioMed Holdings, Inc. on XNAS, run from 2023-01-30 to 2024-05-10 and concern attribution; the buy and sell amounts shown for this sample are EUR 0 each.